Home

Kabra Drugs Ltd EPS

Image

Kabra Drugs Ltd

NSE: KABRADRUGS

EPS

₹ 0.5

Last updated on: Dec 26, 2025

Key Highlights

  • The Earning per Share of Kabra Drugs Ltd is ₹ 0.5 as of 26 Dec 25 .
  • The earning per share of Kabra Drugs Ltd changed from ₹ -0.28 to ₹ 0.77 over 10 quarters. This represents a CAGR of NaN% .

Historical Earning per Share of Kabra Drugs Ltd

No data available

* All values are in

Company Fundamentals for Kabra Drugs Ltd

Market Cap

68 Cr

EPS

0.5

P/E Ratio (TTM)

57.6

P/B Ratio (TTM)

2.6

Day’s High

29.96

Day’s Low

27.93

DTE

0.0

ROE

4.6

52 Week High

32.66

52 Week Low

10.06

ROCE

5.9

Market Price of Kabra Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Kabra Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
26 Dec 202528.8
24 Dec 202529.4
23 Dec 202529.1
22 Dec 202527.72
19 Dec 202526.4
18 Dec 202526.91
17 Dec 202526.96
16 Dec 202527.01
15 Dec 202527.41
12 Dec 202528.37

BlinkX Score for Kabra Drugs Ltd

Asset Value vs Market Value of Kabra Drugs Ltd

Market Value

68

Asset Value

Value addition

1.7 X

25

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Kabra Drugs Ltd68.28
Sun Pharmaceutical Industries Ltd412494
Divis Laboratories Ltd170514
Torrent Pharmaceuticals Ltd129044
Cipla Ltd121574
Dr Reddys Laboratories Ltd105919

Historical Market Cap of Kabra Drugs Ltd

No data available

* All values are in crore

Historical Revenue of Kabra Drugs Ltd

No data available

* All values are in crore

Historical EBITDA of Kabra Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Kabra Drugs Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Kabra Drugs Ltd News Hub

Kabra Drugs reports standalone net loss of Rs 0.55 crore in the June 2024 quarter

Net Loss of Kabra Drugs reported to Rs 0.55 crore in the quarter ended June 2024 as against net loss

Read more

16 Aug 24

Kabra Drugs announces board meeting date

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 14 August 2024. Powered

Read more

09 Aug 24

Kabra Drugs to consider Fund Raising

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 4 November 2024. Powered

Read more

22 Oct 24

Kabra Drugs to conduct board meeting

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 2 September 2024. Powere

Read more

28 Aug 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Kabra Drugs Ltd

What is the EPS of Kabra Drugs Ltd stock?

The Earnings Per Share (EPS) of Kabra Drugs Ltd is 0.5. An EPS is the amount of net income attributed to each share of a common stock.

How is Kabra Drugs Ltd EPS calculated?

The EPS of Kabra Drugs Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Kabra Drugs Ltd report its EPS?

Kabra Drugs Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Kabra Drugs Ltd EPS?

Factors that influence the EPS of Kabra Drugs Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Kabra Drugs Ltd EPS growth indicate future performance?

Yes, consistent growth in Kabra Drugs Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions